Generic Name: thiotepa (THYE oh TEP a)
Brand Name: Thioplex
What is thiotepa?
Thiotepa is a cancer medicine that interferes with the growth and spread of cancer cells in the body.
Thiotepa is used to treat cancer of the breast, ovary, bladder, and others.
Thiotepa may also be used for purposes not listed in this medication guide.
What is the most important information I should know about thiotepa?
Do not use if you are pregnant. It could harm the unborn baby.
Use birth control to prevent pregnancy while you are receiving thiotepa, whether you are a man or a woman.
What should I discuss with my healthcare provider before receiving thiotepa?
You should not receive thiotepa if you are allergic to it.
To make sure thiotepa is safe for you, tell your doctor if you have:
liver or kidney disease;
heart disease; or
Tell your doctor about all other cancer treatments you have recently received, including chemotherapy and radiation.
Using thiotepa may increase your risk of developing other types of cancer, such as leukemia. Ask your doctor about your specific risk.
Do not use thiotepa if you are pregnant. It could harm the unborn baby. Use effective birth control to prevent pregnancy during treatment.
Use birth control to prevent pregnancy while you are receiving thiotepa, whether you are a man or a woman. Thiotepa use by either parent may cause birth defects.
It is not known whether thiotepa passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using this medicine.
How is thiotepa given?
Thiotepa is injected into a vein through an IV, or injected directly into the bladder or other body cavity. A healthcare provider will give you this injection.
When injected into the bladder, you will need to hold the medicine inside your bladder for 2 hours. Tell your caregivers if this causes you a great deal of discomfort. You may need to receive a smaller amount of the medicine to hold it comfortably in your bladder.
If any of this medicine accidentally gets on your skin, wash it thoroughly with soap and warm water.
Thiotepa is usually given once every 1 to 4 weeks. Follow your doctor's dosing instructions very carefully.
Thiotepa can lower blood cells that help your body fight infections and help your blood to clot. Your blood will need to be tested often during treatment and for at least 3 weeks after you stop receiving thiotepa. Your cancer treatments may be delayed based on the results of these tests.
What happens if I miss a dose?
Call your doctor for instructions if you miss an appointment for your thiotepa injection.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while receiving thiotepa?
Avoid being near people who are sick or have infections. Tell your doctor at once if you develop signs of infection.
This medicine can pass into body fluids (urine, feces, vomit). For at least 48 hours after you receive a dose, avoid allowing your body fluids to come into contact with your hands or other surfaces. Caregivers should wear rubber gloves while cleaning up a patient's body fluids, handling contaminated trash or laundry or changing diapers. Wash hands before and after removing gloves. Wash soiled clothing and linens separately from other laundry.
Do not receive a "live" vaccine while using thiotepa. The vaccine may not work as well during this time, and may not fully protect you from disease. Live vaccines include measles, mumps, rubella (MMR), polio, rotavirus, typhoid, yellow fever, varicella (chickenpox), zoster (shingles), and nasal flu (influenza) vaccine.
Thiotepa side effects
Get emergency medical help if you have signs of an allergic reaction: hives; wheezing, difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
pain or burning when you urinate, blood in your urine;
little or no urinating;
easy bruising, unusual bleeding (nose, mouth, vagina, or rectum), purple or red pinpoint spots under your skin;
signs of infection--fever, flu symptoms, mouth and throat ulcers, rapid heart rate, rapid and shallow breathing, fainting;
low red blood cells (anemia)--pale skin, feeling light-headed or short of breath, rapid heart rate, trouble concentrating; or
liver problems--nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).
Common side effects may include:
dizziness, headache, blurred vision;
nausea, vomiting, stomach pain, loss of appetite;
feeling weak or tired;
pain or irritation where the injection was given;
hair loss; or
missed menstrual periods.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
Thiotepa dosing information
Usual Adult Dose for Breast Cancer:
0.3 to 0.4 mg/kg by rapid IV administration once.
Usual Adult Dose for Ovarian Cancer:
0.3 to 0.4 mg/kg by rapid intravenous administration once.
Usual Adult Dose for Serosal Cavity Neoplastic Disease:
0.6 to 0.8 mg/kg by intracavitary injection once
Usual Adult Dose for Bladder Cancer:
30 to 60 mg by intravesical instillation once, for the treatment of superficial bladder tumors
Usual Adult Dose for Lymphoma:
500 to 1000 mg intravenously once, for the treatment of refractory lymphomas
Usual Adult Dose for Malignant Disease:
0.3 to 0.4 mg/kg by rapid IV administration once.
0.6 to 0.8 mg/kg by intracavitary injection once.
0.6 to 0.8 mg/kg by intratumor injection once.
30 to 60 mg by intravesical instillation once.
10 to 15 mg by intrathecal injection once.
500 to 1000 mg IV once.
Usual Pediatric Dose for Malignant Disease:
Sarcomas: 25 to 65 mg/m2 IV as a single dose every 3 to 4 weeks.
Autologous bone marrow transplantation: 300 mg/m2 IV over 3 hours, repeat every 24 hours for 3 doses. The maximum tolerated dose is 1125 mg/m2 over 3 days.
What other drugs will affect thiotepa?
Other drugs may interact with thiotepa, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
More about thiotepa
- Other brands: Thioplex
Related treatment guides
Where can I get more information?
- Your doctor or pharmacist can provide more information about thiotepa.
- Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
- Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2012 Cerner Multum, Inc. Version: 6.05.
Date modified: November 30, 2016
Last reviewed: August 04, 2015